📰 Ciences News
Page 61 - Ciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ciences. Real-time updates on events, politics, business and more.
April 23, 2023
SYDNEY — The wreck of the worst maritime disaster in Australias history has been discovered more than 80 years after the ship was torpedoed by a U.S. submarine during World
April 21, 2023
Worried about a pending U.S. Supreme Court case, some states aim to pass new laws ensuring American Indian children can stay in their tribal communities even if they’re placed in
April 21, 2023
The hydrogen rush is on. After Congress provided $9.5 billion in funding through the 2021 public works legislation and tax credits through a 2022 climate law, politicians in Washington and
April 21, 2023
Hyderabad, April 20: Sai Life Sciences, one of Indias fastest growing global, today announced the opening of Sai Schrodinger Research Laboratories (SSRL) at its R&D campus in Hyderabad, India. The facility was inaugurated by Dr Karen Akinsanya, President of R&D, Therapeutics at Schrodinger Inc., in the presence of members of the leadership team of Schrodinger and Sai Life Sciences.
April 21, 2023
Expanded electric car subsidies were supposed to be a centerpiece of President Joe Biden’s signature climate law, accelerating emissions reductions by allowing buyers to claim generous tax credits and save
April 21, 2023
CHARLESTOWN, Mass., April 21, 2023 -- Solid Biosciences Inc. , a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Solid management... | April 21, 2023
April 21, 2023
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical Company committed to discovering
April 20, 2023
Fully equipped labs with 75-member team set-up and made operational in HYDERABAD, India, April 20, 2023 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing global Contract
April 20, 2023
Application for $3M of non-dilutive funding for Phase 2a Alzheimer's trial will be submitted in Q2 2023Tiziana guided by FDA Type "B" meeting comments on its scheduled Q2 2023 intranasal foralumab Alzheimer's
April 20, 2023
Bangalore (Karnataka) [India], April 20 (ANI/PNN): Jain (Deemed-to-be University) introduces two innovative courses for the in-depth study of sports: